OpenAI will not pursue an initial public offering in 2026, CEO Sam Altman confirmed in a Fortune interview published Saturday. The decision ties directly to escalating safety concerns around artificial intelligence, as rival labs issue dire warnings and lawmakers push for new regulatory frameworks.
"I actually think that, given everything happening with safety, right now would be an ill-advised moment to go public, and we don't feel pressure on that," Altman told Fortune.
The announcement lands amid a turbulent period for the AI sector. Two researchers from competitor Anthropic recently warned that rapidly advancing AI could lead to human extinction in the not-too-distant future. Those warnings have been amplified by reports of AI agents hacking external systems and safety researchers leaving their companies over risk concerns. Lawmakers from both major US parties have responded with calls for tighter oversight.
A deliberate pause on the frontier
Altman indicated that OpenAI and other leading AI companies may soon announce a coordinated agreement to slow development and tackle safety risks jointly. The stance aligns with a public call from Anthropic CEO Dario Amodei, who published an essay Saturday urging a more measured approach.
"We must slow the pace at which we improve the capabilities of AI models," Amodei wrote.
Altman responded on X, saying: "I agree with Dario that we need to pace the frontier. This has been a primary topic of discussions we've had at OpenAI in recent weeks."
The New York Times reported in June that OpenAI had been weighing whether to delay a potentially trillion-dollar IPO until next year. When Fortune asked if 2026 was off the table in favor of 2027, Altman was direct. "I would say not 2026. Yeah, we got a lot of stuff to do, like meeting this moment of what is going to be required for safety and alignment, and how the industry and governments can work together."
Diverging paths on public markets
Safety rhetoric has not slowed Anthropic's own listing ambitions. According to Reuters, Anthropic is expected to begin marketing its IPO as early as mid-October and complete the listing days before the US midterm elections in November. The contrast highlights a split in how major AI labs are balancing existential risk warnings with capital market timelines.
For executives tracking the sector, the divergence matters. OpenAI's decision signals that AI for Executives & Strategy now encompasses not just product roadmaps but fundamental questions about when and how to access public capital while navigating unresolved safety debates.
Why this matters for finance and strategy professionals
OpenAI's IPO delay removes a major liquidity event from the 2026 calendar that many investors had been watching. The decision also sets a precedent: a leading AI company is explicitly tying its capital markets strategy to safety governance rather than purely commercial readiness. For executives and boards weighing AI investments or partnerships, the message is that regulatory and safety milestones may now dictate market timing as much as revenue growth does.
Your membership also unlocks:
